Skip to content
healthcare.dev

POTASSIUM CITRATE EXTENDED RELEASE

NDC 42543-406, POTASSIUM CITRATE, tablet, from Strides Pharma Inc..

Product NDC
42543-406
Status
Listed
Labeler
Strides Pharma Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206813
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42543-406 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM CITRATE5 meq/1

Pharmacologic classes

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]

Package NDCNDC-11Package
42543-406-0142543040601100 TABLET in 1 BOTTLE (42543-406-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5f38b02c-703c-4fc2-b833-654e41bd617f
  • NADAC price for package 42543040601

    GET /v1/drugs/nadac/42543040601

Use it

Look up 42543-406 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42543-406 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42543-406. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.